Search

Search Constraints

You searched for: Author/Creator Basu, B

Search Results

1. 2 Efficacy and safety of lenvatinib plus pembrolizumab in patients with previously treated ovarian cancer in the multicohort phase 2 LEAP-005 study. (13th November 2020)

9. Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer. (17th July 2018)